We are live on ! Find out more
RI

RTW Investments Portfolio holdings

AUM $10B
1-Year Est. Return 135.35%
This Fund
S&P 500
This Quarter Est. Return
+18.12%
1 Year Est. Return
+135.35%
3 Year Est. Return
+383.62%
5 Year Est. Return
+523.94%
10 Year Est. Return
+15,981.64%
AUM
$344M
AUM Growth
+$122M
Cap. Flow
+$79.6M
Cap. Flow %
23.16%
Top 10 Hldgs %
70.07%
Holding
43
New
16
Increased
6
Reduced
4
Closed
7

Top Buys

Rank Stock Value
1
INCY icon
Incyte
INCY
+$20.2M
2
AGEN
Agenus
AGEN
+$14.8M
3
FPRX
Five Prime Therapeutics, Inc.
FPRX
+$12.5M
4
CLDX icon
Celldex Therapeutics
CLDX
+$12.5M
5
ACHN
Achillion Pharmaceuticals
ACHN
+$8.44M

Top Sells

Rank Stock Value
1
DYAX
DYAX CORPORATION
DYAX
+$27.2M
2
LJPC
La Jolla Pharmaceutical Company
LJPC
+$16.1M
3
ZSPH
ZS PHARMA INC COMS TK (DE)
ZSPH
+$3M
4
ASMB icon
Assembly Biosciences
ASMB
+$2.7M
5
ADVM
Adverum Biotechnologies
ADVM
+$2.08M

Sector Composition

Rank Sector Weight
1 Healthcare 72.08%
2 Financials 0%
3 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RPRX
26
DELISTED
Repros Therapeutics Inc.
RPRX
$1.64M 0.48%
229,364
– –
TMBR
27
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
$949K 0.28%
+25
New +$985K
ALPN
28
DELISTED
Alpine Immune Sciences Inc
ALPN
$455K 0.13%
+7,500
New +$447K
ADAP
29
DELISTED
Adaptimmune Therapeutics
ADAP
$367K 0.11%
+20,000
New +$343K
VIVO
30
CALL
DELISTED
Meridian Bioscience Inc
VIVO
– –
0
– –
ZGNX
31
DELISTED
Zogenix, Inc.
ZGNX
$192K 0.06%
+14,266
New +$175K
BHC icon
32
CALL
Bausch Health
BHC
$2.58B
– –
0
– –
FBIO icon
33
Fortress Biotech
FBIO
$104M
$40K 0.01%
794
-32,539
-98% -$1.67M
BRK.B icon
34
Berkshire Hathaway Class B
BRK.B
$1.1T
$7K ﹤0.01%
50
– –
ADVM
35
DELISTED
Adverum Biotechnologies
ADVM
– –
-5,130
Closed -$2.08M
ASMB icon
36
Assembly Biosciences
ASMB
$498M
– –
-17,000
Closed -$2.7M
SHAK icon
37
Shake Shack
SHAK
$2.53B
– –
-500
Closed -$25K
TENX icon
38
Tenax Therapeutics
TENX
$363M
– –
0
– -$8K
TARO
39
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
– –
-8,721
Closed -$1.23M
APEN
40
DELISTED
Apollo Endosurgery, Inc.
APEN
– –
-779
Closed -$148K
RLYP
41
DELISTED
RELYPSA INC COM
RLYP
– –
-31,872
Closed -$1.15M
ZSPH
42
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
– –
-71,315
Closed -$3M
1
2

Similar funds

HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return
IIM
INTECH Investment Management West Palm Beach, Florida $10.2B AUM 28.14% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
FPAS
Focus Partners Advisor Solutions Saint Louis, Missouri $9.92B AUM 21.52% 1-Year Est. Return
VPIM
Vanguard Personalized Indexing Management Oakland, California $10.2B AUM 34.45% 1-Year Est. Return
OIA
OneDigital Investment Advisors Overland Park, Kansas $10.2B AUM 16.58% 1-Year Est. Return

RTW Investments's Q2 2015 Portfolio in Review

As of Q2 2015, RTW Investments held 43 positions worth $344M, up 55% from $222M the previous quarter. Its ten largest holdings account for 70% of the portfolio.

RTW Investments deployed $79.6M of net new capital in Q2 2015, opening 16 new positions and adding to 6 existing holdings. Its largest new stake was Incyte: 195,000 shares worth $20.3M.

By sector, the portfolio is most concentrated in Healthcare at 72% of assets, up from 66% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was DYAX CORPORATION, an estimated $27.2M trimmed.

  • RTW Investments's largest Q2 2015 buy was Incyte: 195,000 shares worth $20.3M.
  • RTW Investments added most to Achillion Pharmaceuticals in Q2 2015, an estimated $8.44M increase.
  • RTW Investments's biggest Q2 2015 reduction was DYAX CORPORATION, cutting an estimated $27.2M.
  • RTW Investments fully exited ZS PHARMA INC COMS TK (DE) in Q2 2015, selling an estimated $3M.
  • RTW Investments's ten largest holdings make up 70% of its $344M portfolio in Q2 2015.
  • RTW Investments opened 16 new positions and closed 7 in Q2 2015.
  • RTW Investments's portfolio value rose 55% quarter-over-quarter to $344M.

Based on RTW Investments's 13F filing for Q2 2015, filed 14 Aug 2015.